In silico structure-based design of peptides or proteins as therapeutic tools for obesity or diabetes mellitus a protocol for systematic review and meta analysis

dc.contributor.authorMedeiros, Isaiane
dc.contributor.authorAguiar, Ana Júlia Felipe Camelo
dc.contributor.authorFortunato, Wendjilla Medeiros
dc.contributor.authorTeixeira, Ana Francisca Gomes
dc.contributor.authorSilva, Emilly Guedes Oliveira e
dc.contributor.authorBezerra, Ingrid Wilza Leal
dc.contributor.authorMaia, Juliana Kelly da Silva
dc.contributor.authorPiuvezam, Grasiela
dc.contributor.authorMorais, Ana Heloneida de Araújo
dc.date.accessioned2023-05-19T21:35:10Z
dc.date.available2023-05-19T21:35:10Z
dc.date.issued2023
dc.description.resumoBackground: In silico studies using dynamic simulation or molecular docking have boosted the screening and identification of molecules and/or targets in studies aimed at treating diseases such as obesity and diabetes mellitus, optimizing the development of new drugs. This study aims to describe a systematic review protocol on peptides and proteins evaluated in silico as potential therapeutic agents for obesity or diabetes mellitus. Methods: This protocol followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocols and was registered in the International Prospective Register of Systematic Reviews database (number: CRD42022355540). The databases to be searched will be PubMed, ScienceDirect, Scopus, Web of Science, virtual health library, and EMBASE. It will be included in silico studies that evaluate the simulation by dynamics or molecular docking of proteins or peptides involved in treating obesity or diabetes mellitus. Two independent reviewers will select studies, extract data, and assess methodological quality using the adapted Strengthening the reporting of empirical simulation studies. A narrative synthesis of the included studies will be performed for the systematic reviews. Results: This protocol contemplates the production of 2 systematic reviews to be developed focusing on obesity or diabetes mellitus. Conclusion: The reviews will enable knowledge of peptides and proteins involved in research treating these diseases and will emphasize the importance of in silico studies in this context and for the development of future studiespt_BR
dc.identifier.citationMEDEIROS, Isaiane et al. In silico structure-based design of peptides or proteins as therapeutic tools for obesity or diabetes mellitus: A protocol for systematic review and meta analysis. Medicine, v. 102, n. 15, 2023. Disponível em: https://journals.lww.com/md-journal/fulltext/2023/04140/in_silico_structure_based_design_of_peptides_or.1.aspx. Acesso em: 18 de mai. de 2023pt_BR
dc.identifier.issn1536-5964
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/52492
dc.languageenpt_BR
dc.publisherMedicinept_BR
dc.subjectdiabetespt_BR
dc.subjectmolecular docking simulationpt_BR
dc.subjectoverweightpt_BR
dc.subjectpeptidespt_BR
dc.subjectproteinpt_BR
dc.subjectsystematic reviewpt_BR
dc.titleIn silico structure-based design of peptides or proteins as therapeutic tools for obesity or diabetes mellitus a protocol for systematic review and meta analysispt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
Insilicostructurebaseddesignofpeptides_Medeiros_2023.pdf
Tamanho:
646.53 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar